Preoperative serum markers for individual patient prognosis in stage I–III colon cancer

@article{GiessenJung2015PreoperativeSM,
  title={Preoperative serum markers for individual patient prognosis in stage I–III colon cancer},
  author={Clemens Giessen-Jung and Dorothea Nagel and Maria Glas and Fritz Spelsberg and Ulla Lau-Werner and Dominik Paul Modest and Christoph Schulz and Volker Heinemann and Dorit Di Gioia and Petra Stieber},
  journal={Tumor Biology},
  year={2015},
  volume={36},
  pages={7897-7906}
}
Carcinoembryonic antigen (CEA) remains the only recommended biomarker for follow-up care of colorectal cancer (CRC), but besides CEA, several other serological parameters have been proposed as prognostic markers for CRC. The present retrospective analysis investigates a comprehensive set of serum markers with regard to cancer-specific survival (CSS) and disease-free survival (DFS). A total of 472 patients with colon cancer underwent surgery for curative intent between January 1988 and June 2007… CONTINUE READING
7 Citations
29 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Prognosis in non-metastatic colorectal cancer: multivariate evaluation of preoperative levels of six tumor markers in addition to clinical parameters

  • D Hofmann, D Nagel, U Lau-Werner, W Wichmann Matthias, H-M Hornung, H Stenman Ulf
  • Lab Med
  • 2007
Highly Influential
7 Excerpts

an integrative oncology approach

  • SH Jafri, Mills G. Lifestyle modification in colorectal cancer patients
  • Future Oncol. 2013;9(2): 207–18. 7906 Tumor…
  • 2015
1 Excerpt

Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype

  • Y Zhu, SR Yang, PP Wang, S Savas, T Wish, J Zhao
  • Br J Cancer
  • 2014
1 Excerpt

Similar Papers

Loading similar papers…